the formula (insulin (μU/mL) × glycemia (mg/dL)/405 ( 38 , 39 ). HOMA-B = 20 × fasting insulin (μU/mL)/(fasting plasma glucose (mg/dL) – 63) ( 39 ). The Nugent test excluded Cushing’s syndrome (cortisol radioimmunoassay; normal cortisol values after 1
Search Results
Eliana Piantanida, Daniela Gallo, Giovanni Veronesi, Eugenia Dozio, Eugenia Trotti, Adriana Lai, Silvia Ippolito, Jessica Sabatino, Maria Laura Tanda, Antonio Toniolo, Marco Ferrario, and Luigi Bartalena
Gamze Akkuş, Isa Burak Güney, Fesih Ok, Mehtap Evran, Volkan Izol, Şeyda Erdoğan, Yıldırım Bayazıt, Murat Sert, and Tamer Tetiker
, radiographic and pathological features. N Mass size (cm) SUV max (mean ± s.d. ) Pathological diagnosis P Non-functional-nonoperated adrenal masses 96 2.2 ± 3.1 (range 1–8) 3.23 ± 1.65 – 0.066 Cushing syndrome 4
Karim Gariani, Pedro Marques-Vidal, Gérard Waeber, Peter Vollenweider, and François R Jornayvaz
; F R J analyzed data and wrote part of the manuscript. P M V had full access to the data and is the guarantor of the study. References 1 Clayton RN Raskauskiene D Reulen RC Jones PW . Mortality and morbidity in Cushing’s disease
Mírian Romitti, Vitor C Fabris, Patricia K Ziegelmann, Ana Luiza Maia, and Poli Mara Spritzer
intervention (I) was defined as diagnosis of PCOS; the comparison group (C) corresponded to women without PCOS; the outcome (O) was defined as autoimmune thyroid disease (AITD) and the study design (S) was defined to include non-interventional case control
Qiuli Liu, Lin-ang Wang, Jian Su, Dali Tong, Weihua Lan, Luofu Wang, Gaolei Liu, Jun Zhang, Victor Wei Zhang, Dianzheng Zhang, Rongrong Chen, Qingyi Zhu, and Jun Jiang
( 8 ). CAH and Cushing’s syndrome are two of the most common causes of adrenal myelolipomas ( 9 ), and 4% of patients with CAH will develop a myelolipoma ( 10 ). In this report, we describe two adult families with CAH-associated giant adrenal
Marloes L P Langelaan, Jérôme M H Kisters, Mirjam M Oosterwerff, and Arjen-Kars Boer
Introduction The utility of measuring salivary cortisol has become increasingly popular in, for example, screening for Cushing’s syndrome or disease ( 1 , 2 ). Obtaining salivary samples is easy and patient friendly. An additional advantage
Sylvia Thiele, Anke Hannemann, Maria Winzer, Ulrike Baschant, Heike Weidner, Matthias Nauck, Rajesh V Thakker, Martin Bornhäuser, Lorenz C Hofbauer, and Martina Rauner
treatment period, mice were killed to examine the effects on the skeleton. In addition, a mouse model for Cushing’s syndrome due to an N-ethyl-N-nitrosourea (ENU) induced mutation at −120 bp of the promoter region of the corticotropin releasing hormone
Filippo Ceccato, Elisa Selmin, Chiara Sabbadin, Miriam Dalla Costa, Giorgia Antonelli, Mario Plebani, Mattia Barbot, Corrado Betterle, Marco Boscaro, and Carla Scaroni
life; in the latter, the AI patients are prone to develop metabolic and cardiovascular consequences as those observed in Cushing’s syndrome (CS) ( 7 , 8 , 9 ). Recently, dual-release HC (DR-HC) has been introduced: it consists in an immediate
Stephanie Burger-Stritt, Linda Bachmann, Max Kurlbaum, and Stefanie Hahner
Hurley DM Funder JW Stockigt JR . Steroid replacement in Addison’s disease and in subjects adrenalectomized for Cushing’s disease: comparison of various glucocorticoids . Journal of Clinical Endocrinology and Metabolism 1982 55 551 – 559 . ( https
Paraskevi Kazakou, Stavroula A Paschou, Theodora Psaltopoulou, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia N Kassi, Meletios-Athanasios Dimopoulos, and Asimina Mitrakou
response, as they secrete cortisol and catecholamines. Patients with known adrenal insufficiency and Cushing’s syndrome present higher susceptibility to infections, and special attention is required during the pandemic ( 8 , 9 , 10 ). Few clinical cases